GS

Gavin Spencer

Executive Vice President and Chief Business Officer | Number two to the CEO

Nicox

Nice, Provence-Alpes-Cote d'Azur


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Nicox
Industry
pharmaceuticals
Employees
46.0
Seniority
C suite
Annual Revenue
7881000.0

Technologies

MailJet Outlook Microsoft Office 365 OpenSSL WordPress.org Apache Gravity Forms Mobile Friendly

Keywords

pharmaceuticals ophthalmology research & development pharmaceutical manufacturing glaucoma ocular health nitric oxide iop lowering ncx 470 clinical trials ocular hypertension dry eye disease allergic conjunctivitis vyzulta zerviate bimatoprost pde5 inhibitor retinal conditions phase 3 clinical development eye care ocular therapeutics innovation prostaglandin analog ocular perfusion drug development exclusive licensing ocular solutions clinical candidate retinal protection nitric oxide-donating marketed products drug efficacy ocular pharmacology fda approval clinical research lasers treatment options patient education therapeutic applications biotechnology partnerships drug safety ophthalmic pipeline patient outcomes vision loss prevention clinical evaluations contract manufacturing global markets research collaboration therapeutic development medical health care health wellness & fitness hospital & health care mechanical or industrial engineering

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans